Your browser doesn't support javascript.
loading
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial.
Khanna, Dinesh; Allanore, Yannick; Denton, Christopher P; Kuwana, Masataka; Matucci-Cerinic, Marco; Pope, Janet E; Atsumi, Tatsuya; Becvár, Radim; Czirják, László; Hachulla, Eric; Ishii, Tomonori; Ishikawa, Osamu; Johnson, Sindhu R; De Langhe, Ellen; Stagnaro, Chiara; Riccieri, Valeria; Schiopu, Elena; Silver, Richard M; Smith, Vanessa; Steen, Virginia; Stevens, Wendy; Szücs, Gabriella; Truchetet, Marie-Elise; Wosnitza, Melanie; Laapas, Kaisa; de Oliveira Pena, Janethe; Yao, Zhen; Kramer, Frank; Distler, Oliver.
Afiliação
  • Khanna D; Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA khannad@med.umich.edu oliver.distler@usz.ch.
  • Allanore Y; Rheumatology A department, Cochin Hospital, APHP, Paris Descartes University, Paris, France.
  • Denton CP; Division of Medicine, Centre for Rheumatology, University College London, London, UK.
  • Kuwana M; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
  • Matucci-Cerinic M; Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.
  • Pope JE; Schulich School of Medicine, Division of Rheumatology, The University of Western Ontario, London, Ontario, Canada.
  • Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Becvár R; Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Czirják L; Department of Rheumatology and Immunology, University of Pécs, Pécs, Hungary.
  • Hachulla E; Department of Internal Medicine and Clinical Immunology, Claude Huriez Hospital, Lille University School of Medicine, Lille, France.
  • Ishii T; Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan.
  • Ishikawa O; Department of Dermatology, Gunma University Postgraduate School of Medicine, Maebashi, Japan.
  • Johnson SR; Division of Rheumatology, Department of Medicine, Toronto Western Hospital, University Health Network, Mount Sinai Hospital, University of Toronto, Toronto Scleroderma Research Program, Toronto, Ontario, Canada.
  • De Langhe E; Laboratory of Tissue Homeostasis and Disease, Skeletal Biology and Engineering Research Center, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
  • Stagnaro C; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Riccieri V; Department of Clinical Medicine and Therapy, University of Rome La Sapienza, Rome, Italy.
  • Schiopu E; Division of Rheumatology, Department of Internal Medicine, Michigan Medicine University Hospitals, Ann Arbor, Michigan, USA.
  • Silver RM; Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Smith V; Department of Rheumatology and Internal Medicine, Ghent University Hospital, Ghent, Belgium.
  • Steen V; Division of Rheumatology, Georgetown University Medical Center, Washington, DC, USA.
  • Stevens W; Department of Rheumatology, St. Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
  • Szücs G; Division of Rheumatology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary.
  • Truchetet ME; Department of Rheumatology, CHU Bordeaux, Bordeaux, France.
  • Wosnitza M; Research & Development, Bayer AG, Wuppertal, Germany.
  • Laapas K; StatFinn Oy, Espoo, Finland.
  • de Oliveira Pena J; Bayer HealthCare Pharmaceuticals Inc, Whippany, New Jersey, USA.
  • Yao Z; Bayer Healthcare, Beijing, China.
  • Kramer F; Research & Development, Bayer AG, Wuppertal, Germany.
  • Distler O; Department of Rheumatology, University Hospital, Zurich, Switzerland khannad@med.umich.edu oliver.distler@usz.ch.
Ann Rheum Dis ; 79(5): 618-625, 2020 05.
Article em En | MEDLINE | ID: mdl-32299845
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Ativadores de Enzimas / Esclerodermia Difusa Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Ativadores de Enzimas / Esclerodermia Difusa Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article